Real-time enrollment status for this glaucoma and ocular hypertension clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:06 PM UTC
| NCT Number | NCT04967989 |
| Recruiting Status | Recruiting |
| Condition | Glaucoma and Ocular Hypertension |
| Phase | PHASE3 |
| Target Enrollment | 790 participants |
| Active Locations | 28 sites in the US |
| Sponsor | University of Pittsburgh |
| Last Updated on CT.gov | August 14, 2026 (Aug 14, 2026) |
As of October 12, 2026: Clinical trial NCT04967989 is currently recruiting participants. This phase3 study for glaucoma and ocular hypertension is actively seeking new participants at 28 locations across the United States. The study is sponsored by University of Pittsburgh. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04967989 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04967989 was last updated Aug 14, 2026 (August 14, 2026). HelloStudys verifies this status automatically.